137 related articles for article (PubMed ID: 22649695)
1. Effective Genetic Expression of Nanoantibodies by Recombinant Adenoviral Vector in vitro.
Gribova IY; Tillib SV; Tutykhina IL; Shmarov CE; Logunov DY; Verkhovskaya LV; Naroditskii BS; Gintsburg AL
Acta Naturae; 2011 Jul; 3(3):64-70. PubMed ID: 22649695
[TBL] [Abstract][Full Text] [Related]
2. ["Camel nanoantibody" is an efficient tool for research, diagnostics and therapy].
Tillib SV
Mol Biol (Mosk); 2011; 45(1):77-85. PubMed ID: 21485499
[TBL] [Abstract][Full Text] [Related]
3. Fingerprint-like Analysis of "Nanoantibody" Selection by Phage Display Using Two Helper Phage Variants.
Tillib SV; Ivanova TI; Vasilev LA
Acta Naturae; 2010 Jul; 2(3):85-93. PubMed ID: 22649655
[TBL] [Abstract][Full Text] [Related]
4. Construction of a pIX-modified Adenovirus Vector Able to Effectively Bind to Nanoantibodies for Targeting.
Garas MN; Tillib SV; Zubkova OV; Rogozhin VN; Ivanova TI; Vasilev LA; Logunov DY; Shmarov MM; Tutykhina IL; Esmagambetov IB; Gribova IY; Bandelyuk AS; Naroditsky BS; Gintsburg AL
Acta Naturae; 2014 Apr; 6(2):95-105. PubMed ID: 25093116
[TBL] [Abstract][Full Text] [Related]
5. Induction of a Protective Heterosubtypic Immune Response Against the Influenza Virus by using Recombinant Adenoviral Vectors Expressing Hemagglutinin of the Influenza H5 Virus.
Shmarov MM; Sedova ES; Verkhovskaya LV; Rudneva IA; Bogacheva EA; Barykova YA; Shcherbinin DN; Lysenko AA; Tutykhina IL; Logunov DY; Smirnov YA; Naroditsky BS; Gintsburg AL
Acta Naturae; 2010 Apr; 2(1):111-8. PubMed ID: 22649637
[TBL] [Abstract][Full Text] [Related]
6. [Single-domain adapted antibodies against Chlamydia trachomatis, preserving the development of chlamidic infection in vitro].
Tillib SV; Morgunova EY; Ivanova TI; Koroleva EA; Rutovskaya MV; Zigangirova NA
Biomed Khim; 2017 Oct; 63(5):461-466. PubMed ID: 29080882
[TBL] [Abstract][Full Text] [Related]
7. A novel and simple method for construction of recombinant adenoviruses.
Tan R; Li C; Jiang S; Ma L
Nucleic Acids Res; 2006 Jul; 34(12):e89. PubMed ID: 16855284
[TBL] [Abstract][Full Text] [Related]
8. [Protective properties of candidate genetically engineered vaccines against avian influenza viruses constructed on the basis of recombinant adenoviral vectors].
Sedova ES; Shmarov MM; Tutykhina IL; Barykova IuA; Verkhovskaia LV; Logunov DIu; Naroditskiĭ BS; Gintsburg AL
Zh Mikrobiol Epidemiol Immunobiol; 2010; (3):44-8. PubMed ID: 20734718
[TBL] [Abstract][Full Text] [Related]
9. [Construction of adenoviral vector carrying Smad3D or Smad7].
Qin J; Zhou Q; Qin Y; Sun Z; Zhao F; Sun Z; Wang Y; Yi C; Zhu W
Zhongguo Fei Ai Za Zhi; 2003 Jun; 6(3):169-71. PubMed ID: 21266111
[TBL] [Abstract][Full Text] [Related]
10. Llama nanoantibodies with therapeutic potential against human norovirus diarrhea.
Garaicoechea L; Aguilar A; Parra GI; Bok M; Sosnovtsev SV; Canziani G; Green KY; Bok K; Parreño V
PLoS One; 2015; 10(8):e0133665. PubMed ID: 26267898
[TBL] [Abstract][Full Text] [Related]
11. Recombinant adenoviral vector expressing HCV NS4 induces protective immune responses in a mouse model of Vaccinia-HCV virus infection: a dose and route conundrum.
Singh S; Vedi S; Li W; Samrat SK; Kumar R; Agrawal B
Vaccine; 2014 May; 32(23):2712-21. PubMed ID: 24631092
[TBL] [Abstract][Full Text] [Related]
12. Nanoantibodies for detection and blocking of bioactivity of human vascular endothelial growth factor A(165).
Tillib SV; Ivanova TI; Lyssuk EY; Larin SS; Kibardin AV; Korobko EV; Vikhreva PN; Gnuchev NV; Georgiev GP; Korobko IV
Biochemistry (Mosc); 2012 Jun; 77(6):659-65. PubMed ID: 22817466
[TBL] [Abstract][Full Text] [Related]
13. Use of the cosmid adenoviral vector cloning system for the in vitro construction of recombinant adenoviral vectors.
Fu S; Deisseroth AB
Hum Gene Ther; 1997 Jul; 8(11):1321-30. PubMed ID: 9295127
[TBL] [Abstract][Full Text] [Related]
14. [Prokaryotic expression of prostate-specific membrane antigen (PSMA) nanoantibody gene and screening of natural phage nanoantibody library].
Zhang X; Chen K; Jiang K; He J; An Y; He Z; Sun F
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2022 Nov; 38(11):1030-1035. PubMed ID: 36328433
[TBL] [Abstract][Full Text] [Related]
15. [Construction of recombinant adenovirus expressing
Zhang H; Xu J; Cheng Y; Fu S; Liu Y; Hu Y; DU Y; Bao F
Sheng Wu Gong Cheng Xue Bao; 2022 Sep; 38(9):3551-3562. PubMed ID: 36151821
[TBL] [Abstract][Full Text] [Related]
16. Constructing adenoviral vectors by using the circular form of the adenoviral genome cloned in a cosmid and the Cre-loxP recombination system.
Tashiro F; Niwa H; Miyazaki J
Hum Gene Ther; 1999 Jul; 10(11):1845-52. PubMed ID: 10446924
[TBL] [Abstract][Full Text] [Related]
17. Improved vascular gene transfer with a helper-dependent adenoviral vector.
Wen S; Graf S; Massey PG; Dichek DA
Circulation; 2004 Sep; 110(11):1484-91. PubMed ID: 15326058
[TBL] [Abstract][Full Text] [Related]
18. Preparation and identification of a single domain antibody specific for adenovirus vectors and its application to the immunoaffinity purification of adenoviruses.
Cheng Y; Hao Y; Bao F; Zhang H; Liu Y; Ao K; Fu S; Wu Q; Wang Z
AMB Express; 2022 Jun; 12(1):80. PubMed ID: 35723787
[TBL] [Abstract][Full Text] [Related]
19. Immune responses to reporter proteins and high viral dose limit duration of expression with adenoviral vectors: comparison of E2a wild type and E2a deleted vectors.
Morral N; O'Neal W; Zhou H; Langston C; Beaudet A
Hum Gene Ther; 1997 Jul; 8(10):1275-86. PubMed ID: 9215744
[TBL] [Abstract][Full Text] [Related]
20. Generation of recombinant adenovirus vector with infectious adenoviral genome released from cosmid-based vector by simple procedure allowing complex manipulation.
Kojima H; Ohishi N; Yagi K
Biochem Biophys Res Commun; 1998 May; 246(3):868-72. PubMed ID: 9618304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
